As of 2026-06-21, the Relative Valuation of Seres Therapeutics Inc (MCRB) is (43.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.61 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is -764.7%.
The range of the Relative Valuation is (80.91) - 9.91 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 23.4x | 20.0x |
| Forward P/E multiples | 18.5x - 21.3x | 19.9x |
| Fair Price | (80.91) - 9.91 | (43.94) |
| Upside | -1324.1% - 50.0% | -764.7% |
| Date | P/E |
| 2026-06-15 | -1.16 |
| 2026-06-12 | -1.18 |
| 2026-06-11 | -1.30 |
| 2026-06-10 | -1.34 |
| 2026-06-09 | -1.31 |
| 2026-06-08 | -1.30 |
| 2026-06-05 | -1.37 |
| 2026-06-04 | -1.41 |
| 2026-06-03 | -1.48 |
| 2026-06-02 | -1.51 |
| 2026-06-01 | -1.58 |
| 2026-05-29 | -1.51 |
| 2026-05-28 | -1.56 |
| 2026-05-27 | -1.57 |
| 2026-05-26 | -1.57 |
| 2026-05-22 | -1.63 |
| 2026-05-21 | -1.66 |
| 2026-05-20 | -1.58 |
| 2026-05-19 | -1.54 |
| 2026-05-18 | -1.57 |
| 2026-05-15 | -1.58 |
| 2026-05-14 | -1.66 |
| 2026-05-13 | -1.60 |
| 2026-05-12 | -1.64 |
| 2026-05-11 | -1.62 |
| 2026-05-08 | -1.59 |
| 2026-05-07 | -1.59 |
| 2026-05-06 | -1.65 |
| 2026-05-05 | -1.55 |
| 2026-05-04 | -1.59 |
| 2026-05-01 | -1.57 |
| 2026-04-30 | -1.52 |
| 2026-04-29 | -1.46 |
| 2026-04-28 | -1.46 |
| 2026-04-27 | -1.51 |
| 2026-04-24 | -1.67 |
| 2026-04-23 | -1.67 |
| 2026-04-22 | -1.74 |
| 2026-04-21 | -1.75 |
| 2026-04-20 | -1.85 |
| 2026-04-17 | -1.83 |
| 2026-04-16 | -1.82 |
| 2026-04-15 | -1.82 |
| 2026-04-14 | -1.78 |
| 2026-04-13 | -1.77 |
| 2026-04-10 | -1.72 |
| 2026-04-09 | -1.80 |
| 2026-04-08 | -1.81 |
| 2026-04-07 | -1.83 |
| 2026-04-06 | -1.82 |